• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ-羟基丁酸:一种引发身体依赖的新型滥用药物。

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.

作者信息

Galloway G P, Frederick S L, Staggers F E, Gonzales M, Stalcup S A, Smith D E

机构信息

Haight-Ashbury Free Clinics, San Francisco, California, USA.

出版信息

Addiction. 1997 Jan;92(1):89-96.

PMID:9060200
Abstract

Gamma-hydroxybutyrate (GHB) is a compound found in mammalian brain which meets many criteria of a neurotransmitter. GHB has been investigated as a tool for inducing absence (petit mal) seizures, for use as an anesthetic, and for treatment of narcolepsy, alcohol dependence and opiate dependence. Since 1990 GHB has been abused in the United States for euphoric, sedative and anabolic effects. Coma and seizures have been reported following abuse of GHB, but dependence liability has received little attention. The neuropharmacology, potential therapeutic uses and acute adverse effects of GHB are reviewed, followed by a case series of eight people using GHB. Adverse effects of GHB may include prolonged abuse, seizure activity and a withdrawal syndrome. This withdrawal syndrome includes insomnia, anxiety and tremor; withdrawal symptoms resolve in 3-12 days. GHB has the potential to cause a significant incidence of abuse and adverse effects. Prolonged use of high doses may lead to a withdrawal syndrome, which resolves without sequelae. Educational efforts should address the narrow therapeutic index, possible physical dependence and dangers of combining GHB with other drugs of abuse.

摘要

γ-羟基丁酸(GHB)是一种存在于哺乳动物大脑中的化合物,符合神经递质的多项标准。GHB已被作为一种诱发失神(小发作)性癫痫的工具、一种麻醉剂以及用于治疗发作性睡病、酒精依赖和阿片类药物依赖进行研究。自1990年以来,GHB在美国被滥用,以产生欣快感、镇静作用和合成代谢作用。滥用GHB后曾有昏迷和癫痫发作的报告,但对其成瘾性关注较少。本文综述了GHB的神经药理学、潜在治疗用途和急性不良反应,随后是一个关于8名使用GHB者的病例系列。GHB的不良反应可能包括长期滥用、癫痫活动和戒断综合征。这种戒断综合征包括失眠、焦虑和震颤;戒断症状在3至12天内缓解。GHB有导致大量滥用和不良反应的可能性。长期大剂量使用可能导致戒断综合征,该综合征可自行缓解且无后遗症。教育工作应关注其狭窄的治疗指数、可能的身体依赖性以及将GHB与其他滥用药物合用的危险。

相似文献

1
Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.γ-羟基丁酸:一种引发身体依赖的新型滥用药物。
Addiction. 1997 Jan;92(1):89-96.
2
[Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
Tidsskr Nor Laegeforen. 1998 Nov 20;118(28):4390-3.
3
Gamma-hydroxybutyrate withdrawal syndrome.γ-羟基丁酸戒断综合征
Ann Emerg Med. 2001 Feb;37(2):147-53. doi: 10.1067/mem.2001.112985.
4
[Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].[γ-羟基丁酸(GHB)依赖与GHB戒断综合征:诊断与治疗]
Ned Tijdschr Geneeskd. 2010;154:A1286.
5
Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.γ-羟基丁酸(GHB)和γ-丁内酯(GBL)戒断:五个案例研究
J Psychoactive Drugs. 2001 Apr-Jun;33(2):143-9. doi: 10.1080/02791072.2001.10400479.
6
Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.γ-羟基丁酸(GHB)戒断的临床特征与管理:综述
Drug Alcohol Depend. 2004 Jul 15;75(1):3-9. doi: 10.1016/j.drugalcdep.2004.01.012.
7
[Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].[既往酒精依赖情况下的γ-羟基丁酸(GHB)依赖与戒断]
Psychiatr Prax. 2009 Oct;36(7):345-7. doi: 10.1055/s-0028-1090089. Epub 2009 Jan 27.
8
Gamma-hydroxybutyrate (GHB): a newer drug of abuse.γ-羟基丁酸(GHB):一种新型滥用药物。
Am Fam Physician. 2000 Dec 1;62(11):2478-83.
9
[Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].[γ-羟基丁酸戒断的危及生命症状]
Tijdschr Psychiatr. 2010;52(6):411-6.
10
Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.γ-羟基丁酸戒断临床表现的患者内变异性:一例报告
Eur Addict Res. 2005;11(3):152-4. doi: 10.1159/000085551.

引用本文的文献

1
Acute Gamma-Hydroxybutyrate (GHB) Intoxication Requiring Hemodialysis in Southern Brazil: A Case Report.巴西南部急性γ-羟基丁酸(GHB)中毒需血液透析:病例报告
Cureus. 2025 Jul 11;17(7):e87728. doi: 10.7759/cureus.87728. eCollection 2025 Jul.
2
Repurposing of substances with lactone moiety for the treatment of γ-Hydroxybutyric acid and γ-Butyrolactone intoxication through modulating paraoxonase and PPARγ.通过调节对氧磷酶和过氧化物酶体增殖物激活受体γ,重新利用含内酯部分的物质来治疗γ-羟基丁酸和γ-丁内酯中毒。
Front Pharmacol. 2022 Jul 22;13:909460. doi: 10.3389/fphar.2022.909460. eCollection 2022.
3
Toxicological Characterization of GHB as a Performance-Enhancing Drug.
γ-羟基丁酸(GHB)作为一种提高运动成绩药物的毒理学特征
Front Psychiatry. 2022 Apr 18;13:846983. doi: 10.3389/fpsyt.2022.846983. eCollection 2022.
4
Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.下丘脑泌素/食欲素与去甲肾上腺素的相互作用导致阿片类药物戒断综合征。
J Neurosci. 2022 Jan 12;42(2):255-263. doi: 10.1523/JNEUROSCI.1557-21.2021. Epub 2021 Dec 1.
5
Pleasure, addiction, and hypocretin (orexin).愉悦、成瘾与下丘脑泌素(食欲素)。
Handb Clin Neurol. 2021;180:359-374. doi: 10.1016/B978-0-12-820107-7.00022-7.
6
Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.γ-羟基丁酸(GHB)在临床或娱乐性使用后引起的认知障碍:系统评价。
Curr Neuropharmacol. 2022;20(4):809-819. doi: 10.2174/1570159X19666210610094352.
7
Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.多物质使用模式和新型合成毒品:来自三个美国城市的聚类分析。
PLoS One. 2019 Dec 3;14(12):e0225273. doi: 10.1371/journal.pone.0225273. eCollection 2019.
8
Alcohol Interaction with Cocaine, Methamphetamine, Opioids, Nicotine, Cannabis, and γ-Hydroxybutyric Acid.酒精与可卡因、甲基苯丙胺、阿片类药物、尼古丁、大麻及γ-羟基丁酸的相互作用
Biomedicines. 2019 Mar 7;7(1):16. doi: 10.3390/biomedicines7010016.
9
[Course and complications of GHB detoxification treatment: a 1-year case series].[γ-羟基丁酸解毒治疗的过程及并发症:1年病例系列]
Nervenarzt. 2019 May;90(5):509-515. doi: 10.1007/s00115-018-0636-8.
10
Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability.巴氯芬用于γ-羟基丁酸戒断:使用模式及网络可获取性
Eur J Clin Pharmacol. 2018 Mar;74(3):349-356. doi: 10.1007/s00228-017-2387-z. Epub 2017 Dec 3.